Evidence map›Paper›PMID 28288632›Full record

ArticleMalaria journal2017

Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78.

Irina T Jovel, Anders Björkman, Cally Roper, Andreas Mårtensson, Johan Ursing

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Frontiers in pharmacology · 2021
    Review
  2. Review
  3. Article
  4. Analysis of Plasmodium falciparum NaBMC infectious diseases · 2019
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Irina T JovelMalaria Research, Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden. irina.jovel@ki.se.ORCID 0000-0002-2651-6772
Anders BjörkmanMalaria Research, Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Cally RoperFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Andreas MårtenssonDepartment of Women's and Children's Health, International Maternal and Child Health Unit, Uppsala University, Uppsala, Sweden.
Johan UrsingMalaria Research, Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SEDanderyds sjukhus · SELondon School of Hygiene & Tropical Medicine · GBUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo assess the effect on malaria prevalence, village specific monthly administrations of pyrimethamine, chlorproguanil, chloroquine or placebo were given to children in four previously treatment-naïve Liberian villages, 1976-78. Plasmodium falciparum in vivo resistance developed to pyrimethamine only. Selection of molecular markers of P. falciparum resistance after 2 years of treatment are reported.

methodsBlood samples were collected from 191 study children in a survey in 1978. Polymorphisms in pfcrt, pfmdr1, pfdhfr, pfdhps, pfmrp1 and pfnhe1 genes were determined using PCR-based methods.

resultsPfcrt 72-76 CVIET was found in one chloroquine village sample, all remaining samples had pfcrt CVMNK. Pfmdr1 N86 prevalence was 100%. A pfmdr1 T1069

conclusionsChloroquine treatment possibly resulted in the development of pfcrt 72-76 CVIET. Selection of pfmdr1 T1069

Indexed as

Drug ResistancePolymorphism, GeneticAntimalarialsChildChild, PreschoolChloroquineHumansLiberiaMalaria, FalciparumPlasmodium falciparumPolymerase Chain ReactionProguanilProtozoan ProteinsPyrimethamineSelection, GeneticAntimalarialsChloroquinechlorproguanilProguanilProtozoan ProteinsPyrimethamineLiberiaMalariapfcrtpfdhfrpfdhpspfmdr1pfmrp1pfnhe1Plasmodium falciparumResistance

Identifiers

PMID28288632
PMCPMC5347173
OpenAlexW2596961048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.